Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Avista Pharma Solutions
Avista Pharma Solutions
Activities:
Manufacturing
Analysis
Microbiology
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part II
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
SNIPR Biome receives funding to progress CRISPR medicine SNIPR001 into clinical trials
Phase 1b/2a trial will evaluate SNIPR001 for the prevention of E.coli infections in patients undergoing hematopoietic stem cell transplantation
Kindeva Drug Delivery appoints Denis Johnson as Chief Operating Officer
Denis will be responsible for optimising global operations for the company
SeaBeLife awarded over €1.5 million in i-Nov innovation competition
Funding for company’s SeaBeEYE project will be used to develop a new therapeutic approach for geographic atrophy, a form of age-related macular degeneration
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Cambrex completes acquisition of Avista Pharma Solutions
Cambrex is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialisation of small molecule therapeutics
Manufacturing
Cambrex to acquire Avista Pharma Solutions
Deal adds early stage API and finished dosage form development & testing services to its global contract development & manufacturing network
Finance
Avista expands cleanroom and analytical test offering
Investment at the Agawam facility increases analytical chemistry footprint while new Boston office broader cleanroom services and courier business
Analysis
Avista Pharma Solutions completes expansion of US contract testing facility
The Massachusetts-based company has expanded its microbiology, sterility testing and microbial ID capabilities at the Agawam facility
Design & Build
Avista Pharma Solutions adds a microbiology laboratory at its Massachusetts facility
The CDMO will equip the lab with isolator technology for sterility testing and to increase the analytical footprint
Subscribe now